ARVINDREM Intraday Analysis...

ARVINDREM Share Price

Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A
52 Week Low N/A
ARVINDREM Important Levels
Resistance 2 N/A
Resistance 1 N/A
Pivot N/A
Support 1 N/A
Support 2 N/A
NSE INDIA Most Active Stocks
UNITECH 4.55 -4.21%
ADANIPOWER 31.10 6.69%
CROMPGREAV 68.35 -10.42%
SUNTV 492.60 12.80%
HCC 39.75 -1.97%
HCC 39.75 -1.97%
ASHOKLEY 77.20 3.35%
JPASSOCIAT 7.65 1.32%
HINDALCO 174.50 3.41%
SBIN 256.90 1.10%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.20 33.33%
RAJRAYON 0.30 20.00%
LOTUSEYE 31.95 19.66%
RAJTV 68.90 19.31%
SOMICONVEY 59.75 18.43%
ARIHANT 60.80 17.83%
VISASTEEL 19.35 13.16%
SUNTV 492.60 12.80%
MVL 0.45 12.50%
MVL 0.45 12.50%
More..
NSE INDIA Top Losers Stocks
FCSSOFT 0.25 -16.67%
AUSTRAL 0.30 -14.29%
CROMPGREAV 68.35 -10.42%
SHYAMCENT 9.90 -9.59%
PRAKASH 43.45 -9.57%
NICCO 0.50 -9.09%
SPYL 1.85 -7.50%
DREDGECORP 381.70 -6.37%
TVTODAY 293.80 -6.25%
BALLARPUR 15.65 -6.01%
More..

Arvind Remedies Limited (NSE: ARVINDREM)

ARVINDREM Technical Analysis 1
As on N/A ARVINDREM Share Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
ARVINDREM Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
ARVINDREM Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
ARVINDREM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
ARVINDREM Address
ARVINDREM
N/A
ARVINDREM Latest News
Arvind Remedies Ltd updates on strike by workers   Equity Bulls   - 04th Mar 15
Arvind Remedies: Outcome of board meeting   Moneycontrol.com   - 28th Feb 15
Coronet Labs Pvt. Ltd. ceases to be subsidiary of Arvind Remedies Ltd   Equity Bulls   - 17th Feb 15
Arvind Remedies   Moneycontrol.com   - 03rd Feb 15
Arvind Remedies Limited   Moneycontrol.com   - 06th Jan 15
Arvind Remedies: Updates on strike by workers at Kakkalur   Moneycontrol.com   - 05th Jan 15
Buy Arvind Remedies; target of Rs 100: Ventura   Moneycontrol.com   - 17th Oct 14
Arvind Remedies hits the roof on decision to withdraw demerger plan   Hindu Business Line   - 13th Aug 14
Arvind Remedies' new plant to start by year-end   Business Standard   - 26th Jun 13
Arvind Remedies sets up Rs. 250-cr plant to tap US market   Hindu Business Line   - 25th Jun 13
Interactive Technical Analysis Chart Arvind Remedies Limited ( ARVINDREM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Arvind Remedies Limited
ARVINDREM Business Profile
Arvind Remedies is in the Pharmaceuticals sector. Arvind Remedies Ltd forayed into the world of quality healthcare in 1988 under the dynamic and ambitious stewardship of Dr.Arvind Shah, Managing Director and CEO. Having established our credibility as a company committed to providing world-class healthcare products, we went Public in April 1996 getting listed in Bombay Stock Exchange & National Stock Exchange in Mumbai, Ahmedabad and Chennai Stock Exchanges. The Public Issue comprised of 30 Lakhs Equity Shares priced at Rs.10/- each at a premium of Rs.20/- per share. In the year 1995 the company was converted to limited company. In January 2001, the Company followed this up with a Rights Issue of 14.86 Lakhs Equity Shares of Rs.10/- each for cash at a premium of Rs.90/- per share. During the year 2010-11 the company has increased its authorized share capital to Rs.66 Crores and paid up capital for Rs.48.23 crores with the addition of preferential issue of 22.50 crores equity shares of Rs.1 each at premium of Rs.1.25 per share. During the year 2012-13 company has started commercial operation of its new facility at irungatukottai,Kancheepuram Dt,Tamil nadu , which is plan for registration under USFDA Arvind Remedies' Indian client portfolio includes prestigious Defence Establishments, ESI, CGHS, Central and State Government Institutions, Public Sector Companies, P&T, Railways and World Bank Projects. We have also won international acceptance and recognition with our exports to Africa, Commonwealth of Independent States and Asian countries The current market capitalisation stands at Rs 307.14 crore.The company has reported a standalone sales of Rs 219.65 crore and a Net Profit of Rs 13.13 crore for the quarter ended Sep 2013. The company management includes B Arvind Shah - Managing Director & CEO, Chandra Ravindran - Whole Time Director, C M K Reddy - Director, R Raja Mohan - Director, V R Mehta - Director, Ankur Agarwal - Executive Director, Sudhir Chandra - Additional Director. It is listed on the BSE with a BSE Code of 531823 and the NSE with an NSE Code of ARVINDREM. Its Registered office is at 190, Poonamallee High Road , Chennai (Madras),Tamil Nadu - 600084.